Forward P/S Multiple: Profusa (PFSA)

Profusa Inc - graphic logo of issuer PFSA

The P/S forward indicator in the GURU.Markets terminal confirms the scaling potential of Profusa Inc (PFSA) through the mass production of sensors and software, with the metric reaching the level of 0.00. Stable development is ensured by a strong staff of bioengineers and clinical experts. Profusa Inc (PFSA) creates unique implantable sensors that enable real-time, six-month monitoring of metabolites without tissue scarring.

profusa.com - PFSA Market Cap to Projected Revenue (period 07/15/2025 - 07/15/2025)

Summary analytical data breakdowns for Profusa, Inc (PFSA)

- market price and analyst price targets:
Price Chart Profusa|PFSA - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Profusa, Inc|PFSA - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Profusa|PFSA - Accounting Capitalization|Market Capitalization to Book Value Ratio profusa.com|PFSA - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Profusa Inc|PFSA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Profusa Inc|PFSA - Company Aggregate Debts|Debt to Book Capitalization Ratio Profusa, Inc|PFSA - Company Long-Term Debt|Company Current Liabilities Profusa|Quick Ratio profusa.com
- financial results and valuation multiples details:
PFSA - Company Net Income|Expected Profit Profusa Inc|PFSA - Market Cap to Net Income Ratio|Projected Price to Earnings Profusa, Inc.|PFSA - PEG Multiple|EV/EBITDA Multiple Profusa, Inc|PFSA - Operating income before deduction of amortization|Earnings per share for the last twelve months Profusa|PFSA - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months profusa.com|PFSA - Net earnings per share growth this year|Earnings growth forecast for next year Profusa Inc
- sales and revenue indicators:
PFSA - Company Total Revenue|Company Projected Revenue Profusa|PFSA - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Profusa, Inc
Fundamental company analysis:PFSA (Profusa)
Product sample of Profusa, Inc

For Profusa Inc (PFSA), whose proprietary biosensors create high customer lock-in through integration into medical systems, the forward price-to-sales ratio serves as an indicator of market expectations for technology commercialization. This chart compares current market capitalization with expected annual revenues, where daily recalculations filter out noise, allowing for the identification of fundamental undervaluation or overbought conditions during periods of volatility.

Who Profusa Inc competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|ibs.inc (INBS) - Price-to-Projected Revenue Ratio|Future Price to Revenue XAIR (Beyond Air)|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|GCTK: Forward Price to Sales|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|VERO - Market Cap to Future Revenue Ratio|Forward P/S Multiple NUWE (Nuwellis, Inc.)|AEMD (aethlonmedical.com) - Future Price to Revenue|ASXC: Forward Price-to-Revenue Multiple|AVGR - Forward P/S Multiple|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|CUTR - Market Cap to Expected Sales Ratio|KNW (Know Labs, Inc.) - Forward P/S Multiple|Forward P/S Multiple inarimedical.com|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical Inc.)